Analysis of sequence variation in the polymorphic second exon of the major histocompatibility complex genes HLA-DQa and -DQ( has revealed 8 allelic variants at the a locus and 13 variants at the .3 locus. Correlation of sequence variation with serologic typing suggests that the DQw2, DQw3, and DQ(blank) types are determined by the DQ(3 subunit, while the DQwl specificity is determined by DQa. The haplotypes defined by serologic DR typing are genetically heterogeneous. Stronger associations with IDDM have been found when the serologic specificities are subdivided by restriction fragment length polymorphisms (RFLPs) by using DR(3 and DQ(3 cDNA probes (6-10). In this report, we describe coding sequence polymorphism in the HLA-DQa and -DQj3 loci, determined by amplification using the DNA polymerase chain reaction (PCR) (11) (12) (13) (14) . The Table 3 tTo whom reprint requests should be addressed.
Insulin-dependent diabetes mellitus (IDDM or type I diabetes) is an autoimmune disease in which dysfunctional regulation of glucose metabolism results from the immunologically mediated destruction of the insulin-producing islet cells of the pancreas (1) . The 50% concordance rate of monozygotic twins indicates a significant genetic component for IDDM and suggests, as well, that an "environmental trigger" (e.g., viral infection) may be required to elicit the clinical disease in genetically susceptible individuals. Loci in the HLA (human leukocyte antigen) region of chromosome 6 contribute a major portion of the genetic predisposition, judged on the basis of the concordance rates (25%) of HLA-identical sibs, patterns of haplotype sharing among affected sib pairs, and linkage analysis in families (reviewed in ref. 2 ). In addition, population analysis has revealed that the frequency of certain serologically defined variants ofthe HLA class II antigens is different among patients and controls. These studies found that the serologic types DR3 and DR4 were positively associated with IDDM and DR2 was negatively associated (2) . These disease associations may reflect the function either ofthe class II antigens themselves or of other disease susceptibility genes in linkage disequilibrium with specific class II alleles.
The class II loci of the human major histocompatibility complex (MHC) encode macrophage and B-cell transmembrane glycoproteins that present antigen to the helper T lymphocytes (for review, see ref.
3). Three related class II antigens, each composed of two distinct subunits, a and A, have been identified, and are designated HLA-DR, -DQ, and -DP. These proteins are highly polymorphic, possibly as a result of selective pressure arising from their role in the immunological defense against infectious pathogens (4) . The polymorphism in class II antigens is localized to the NH2-terminal outer domain and is encoded by the second exon. These class II polymorphic residues have been postulated to interact with the T-cell antigen receptor and/or foreign antigen (5) , with recognition of the antigen peptide fragments in association with a specific class II product leading to T-cell activation.
The haplotypes defined by serologic DR typing are genetically heterogeneous. Stronger associations with IDDM have been found when the serologic specificities are subdivided by restriction fragment length polymorphisms (RFLPs) by using DR(3 and DQ(3 cDNA probes (6) (7) (8) (9) (10) . In this report, we describe coding sequence polymorphism in the HLA-DQa and -DQj3 loci, determined by amplification using the DNA polymerase chain reaction (PCR) (11) (12) (13) (14) . The Table 3 ). The location and size of the open reading frame (ORF) for each match were then determined and correlated with the major ORFs and transcriptional segments of the EBV genome (20) . In the six translation phases of EBV, the amino acid residues (one- 0 (n = 3) 9 (n = 9) 56 100 DQw3 0 (n = 8) 1 (n = 16) 48 87 DQ(blank) 0 (n = 2) 2 (n = 4) 56 9 The term "shared unique residues" refers to amino acids common to a specific group of allele products and absent from all other allele products. The amplified regions of the DQ alleles shown in Figs. 1 and 2 were used for this analysis; 23 of these residues are polymorphic for both loci. Listed is the serologic type used to define each group, the number of uniquely shared residues, and the number (n) of sequences compared. The frequency of shared variable residues for each group is also shown. DQ(blank) cells (50) . A more detailed discussion of epitope mapping and of the mechanisms for generating DQ polymorphism will be given elsewhere.
Susceptibility to Autoimmune Disease. (Fig. 2) . It is likely that their differential IDDM susceptibility and TA10 reactivity involve one or more of these residues. The DQB3.3 allele from the DR9 cell line KOZ differs from the DQB3.2 allele only at position 57. KOZ is TA10-, whereas other sequences with the same aspartate substitution at 57 (DQB3.1) are TA10+. Thus, the TA10 epitope does not map to position 57 and, based on the pattern of DQ13 allelic variation, can be tentatively assigned to the region around the glutamate residue at position 45, since this is the only residue that correlates with TA10 reactivity and the DQB3.1 allele.
It is the charge of the residue at position 57, however, that is associated with IDDM susceptibility. As with the DR4 haplotype, DQ(3 allelic variation defines subtypes of the DRw6 haplotype (DQBI.3, DQB1.6, and DQB1.7). The DQ(3 sequence derived from three DRw6 IDDM patients contained valine at position 57 (DQB1 .7), while the DQf3 sequence from two DRw6 homozygous typing cells contained aspartate (DQBI .6) (Fig. 2) . The analysis of PCR-amplified DNA with sequence-specific oligonucleotide probes (13) revealed that the DQBI .7 allele (encoding Val-57), which is associated with the rare DRw6, Dwl9 subtype, was present in all (7/7) of the DRw6 patients and 3/13 DRw6 controls. Most DRw6 controls had the DQBI.6 allele (Asp-57) associated with the Dw18 subtype (unpublished data).
The correlation between residue 57 in the DQ13 chain and IDDM susceptibility extends beyond the DR4 and DRw6 subtypes, discussed above, to the general pattern ofhaplotypic disease association (see Table 3 and Discussion). DQ, 8 allelic variation subdivides the negatively associated DR2 haplotype into the common alleles DQBI.4 and DQBI.5. These correspond to the mixed-lymphocyte-culture-defined §This analysis involves only those residues encoded in the amplified region. Four Fig. 1 and aligned to show patterns of homology. See the legend to Fig. 1 
DISCUSSION
Sequence analysis of HLA-DQ alleles from different serologically defined haplotypes has revealed, thus far, 8 allelic variants at the DQa locus and 13 at DQB. This sequence information can provide the basis of a simple DNA typing system utilizing PCR amplification and sequence-specific oligonucleotide probes (13) . In addition, the availability of this sequence information makes possible the identification of putative epitopes recognized by alloreactive antibodies or T-cell clones, as well as of putative disease-associated epitopes. The pattern of allelic sequence variation within the DQa and DQB loci (Figs. 1 and 2 and Table 1) suggests that the DQwl-specific typing sera recognize polymorphic epitopes on the a chain, while the DQw2, DQw3, and DQ(blank) types are determined by epitopes on the P chain. Since many of these sequences have been-obtained from IDDM patients, the pattern of sequence variation from patients and controls could be compared. Also, polymorphism within the DQ alleles could be correlated with the known IDDM susceptibility of the major HLA types. For example, the DR3 and DR4 serologic types are found at increased frequency in type 1 diabetics, whereas DR2 is decreased (2) . Variation in the amino acid residue at position 57 in the DQB alleles correlates well with the haplotypic susceptibility defined by these population studies (Table 3) . That is, only the more frequent D0J allele in the DR4 diabetics (i.e., DQB3.2) and the DQB2 allele found in the DR3 haplotype have the hydrophobic residue alanine at this position. The alleles from the negatively associated DR2 and DR4 (DQB3.1) haplotypes share the charged residue aspartate at position 57, as does the DQOJ sequence from DR5 haplotypes. Recently, the DR5 haplotype has also been reported to show decreased frequency among IDDM patients An environmental "triggering" agent, such as viral infection, may also be required for the disease to develop in genetically susceptible individuals (15) . If this region of the DQB protein is closely involved with its immunologic function, then it could conceivably also be a target of molecular mimicry by pathogens to escape the host's immune defenses. Alternatively, a shared peptide could serve as an auto-antigen target for a cross-reactive immune response to the pathogen. Potential peptide epitopes that include position 57 encoded by the DQB3.2 (DR4) allele are more similar to the persistent viral pathogen EBV than are peptides encoded by the negatively associated DQBI.4 (DR2) allele (Table 2) ; many of the DR4-associated peptides are found in repeated segments of the EBV genome (48) . Particularly striking is a segment in the BERF4 ORF near position 100137 of EBV (20) , which encodes a six-fold direct repeat of the G P P A A epitope found at position 57 in the DQB3.2 allele product. Repeated structures of this type are known to be more immunogenic than isolated epitopes (49). The G P P A A peptide is also found at position 261 of the El envelope protein of rubella virus (43), a virus implicated in the pathogenesis of IDDM (42) 
